ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...
One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...
Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks ...
UNDATED (WKRC/CNN Newsource) - Recent research indicates that beta blockers, long used as a first-line treatment after heart attacks, may not benefit the majority of patients and could even increase ...
Add Yahoo as a preferred source to see more of our stories on Google. ECG test with tablets Millions of people worldwide take beta blockers to reduce the risk of cardiovascular problems, especially ...
Beta blockers are quickly becoming the hot new drug to combat anxiety. The medication, also known as propranolol, was approved by the U.S. Food and Drug Administration in 1967 for the treatment of ...
A new major trial shows that beta-blockers don't provide any real benefit to people with the most common form of heart attack. Reading time 3 minutes A common treatment given after heart attacks may ...
Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...
In two large studies of heart attack survivors, beta-blocker drugs benefited those with mildly impaired heart function Contradictory trial results seen in patients without heart dysfunction More data ...
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in ...
NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results